We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Disseminated herpes zoster in an immune‐competent patient after SARS‐CoV‐2 vaccine (BNT162b2 Comirnaty, Pfizer).
- Authors
Zengarini, C.; Misciali, C.; Ferrari, T.; Dika, E.; La Placa, M.; Piraccini, B.M.; Baraldi, C.
- Abstract
Causes of its apparition may be found in constitutive or temporal alteration, especially in healthy hosts, in cellular immunity.2 Here, we present a case of a healthy patient who developed a disseminated varicelloid eruption following vaccination with the Pfizer/BioNTech mRNA vaccine. To rule out a first-time varicella infection caused by the varicella-zoster virus (VZV), we asked permission to check the patient's vaccination record and prescribed a chest X-ray,2,3 a blood smear, infections viral panel, HIV, HBV, HCV, IgG and IgM for VZV. Disseminated herpes zoster is defined as a generalized eruption of more than 10-12 extra-dermatomal vesicles after the onset of classic dermatomal herpes zoster,1 often can be indistinguishable from first-time varicella infection (chickenpox).
- Publication
Journal of the European Academy of Dermatology & Venereology, 2022, Vol 36, Issue 8, pe622
- ISSN
0926-9959
- Publication type
Academic Journal
- DOI
10.1111/jdv.18154